People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more aggressive push to regain U.S. market share. “Wegovy (semaglutide) injection 0.25 ...

Novo Nordisk (NVO) announced that Wegovy injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited time price of $199 per month to ...

Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...

Danish drugmaker Novo Nordisk is cutting U.S. supply on certain dose strengths of its highly sought-after weight loss drug Wegovy due to strong demand. Novo Nordisk – whose obesity care sales are ...

Credit: Getty Images. Wegovy is a glucagon-like peptide-1 receptor agonist. Certain dosage strengths of Wegovy (semaglutide) will be in short supply through September 2023, according to Novo Nordisk.

John Morton, M.D., M.P.H. Obesity / Health Care Policy Dr. John Morton is the system lead for surgical quality and bariatric services in the Yale New Haven Health System of six hospitals. He is also ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!

Aug 13 (Reuters) - Eli Lilly (LLY.N), opens new tab on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting ...

Is your Wegovy real? Here’s how to ID fake weight loss drugs Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy ...